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Purpose: The present study examines the role of Sox11 in the initial response of retinal
ganglion cells (RGCs) to axon damage and in optic nerve regeneration in mouse.
Methods: Markers of retinal injury were identified using the normal retina database
and optic nerve crush (ONC) database on GeneNetwork2 (www.genenetwork.org). One
gene, Sox11, was highly upregulated following ONC. We examined the role of this
transcription factor, Sox11, following ONC and optic nerve regeneration in mice. In situ
hybridization was performed using the Affymetrix 2-plex Quantigene View RNA In Situ
Hybridization Tissue Assay System. Sox11 was partially knocked out by intravitreal
injection of AAV2-CMV-Cre-GFP in Sox11f/f mice. Optic nerve regeneration model used
Pten knockdown. Mice were perfused and the retinas and optic nerves were dissected
and examined for RGC survival and axon growth.
Results: Sox11 was dramatically upregulated in the retina following ONC injury. The
level of Sox11 message increased by approximately eightfold 2 days after ONC. In situ
hybridization demonstrated low-level Sox11 message in RGCs and cells in the inner
nuclear layer in the normal retina as well as a profound increase in Sox11 message
within the ganglion cells following ONC. In Sox11f/f retinas, partially knocking out
Sox11 significantly increased RGC survival after ONC as compared to the AAV2-CMV-
GFP control group; however, it had little effect on the ability of axon regeneration.
Combinatorial downregulation of both Sox11 and Pten resulted in a significant increase
in RGC survival as compared to Pten knockdown only. When Pten was knocked down
there was a remarkable increase in the number and the length of regenerating axons.
Partially knocking out Sox11 in combination with Pten deletion resulted in a fewer
regenerating axons.
Conclusion: Taken together, these data demonstrate that Sox11 is involved in the initial
response of the retina to injury, playing a role in the early attempts of axon regeneration
and neuronal survival. Downregulation of Sox11 aids in RGC survival following injury of
optic nerve axons, while a partial knockout of Sox11 negates the axon regeneration
stimulated by Pten knockdown.
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INTRODUCTION
Advances in our ability to monitor molecular changes in
neurons have led to an increased understanding of the events that
transpire following neuronal injury (Howell et al., 2011; Moore
and Goldberg, 2011; Vazquez-Chona and Geisert, 2012; Munguba
et al., 2013; Templeton et al., 2013). After axonal damage, the
initial response of a central nervous system (CNS) neuron may be
similar to that of a neuron in the peripheral nervous system (PNS)
(Carlstedt, 1997). Ultimately, neurons in the PNS will regenerate
their axons and survive, while those in the CNS do not regenerate
their axons and the cell bodies die. The initial response of the CNS
neurons to regenerate and eventual failure of this regenerative
response was described by Ramón y Cajal and termed “abortive
regeneration” (Ramón et al., 1928). When examining the initial
response of neurons to injury, there are some common responses
in the CNS and PNS. One transcription factor activated in both
the CNS and PNS after injury is Sox11 (McCurley and Callard,
2010; Struebing et al., 2017). There is strong evidence that this
gene is part of the transcriptional network activated by injury
and involved in axonal regeneration in the PNS (Jankowski et al.,
2009; Jing et al., 2012).
Sox11 is a member of the SRY-related box group C (SoxC)
gene family of transcription factors (Schepers et al., 2002; Pillai-
Kastoori et al., 2015). Among these, SOX11 and SOX4 play
a critical role in the normal development of neurons and
specifically retinal ganglion cells (RGCs) (Jiang et al., 2013; Usui
et al., 2013a; Wang et al., 2013). SOX11 is expressed in retinal
progenitor cells as part of the process leading progenitor cells to
become neuroblasts (Haslinger et al., 2009; Usui et al., 2013b). In
knockdown of either Sox11 or Sox4, there is a moderate reduction
in RGC number; however when both Sox11 and Sox4 are knocked
down, there is a complete loss of ganglion cell development (Jiang
et al., 2013). During eye development, Sox11 is also required
to maintain proper levels of hedgehog signaling, and mutations
have been associated with coloboma due to improper optic
fissure closure (Pillai-Kastoori et al., 2014; Wen et al., 2015).
Furthermore, SOX11 is critical for axonal growth, driving the
expression of axon growth-related proteins such as class III beta
tubulin and MAP2 (Bergsland et al., 2006). SOX11 also plays a
similar role in adult neurogenesis. High levels of SOX11 are found
in the cells within the subventricular zone, the rostral migratory
stream and within the neuroprogenitor zone of the dentate gyrus
(Tanaka et al., 2004; Haslinger et al., 2009; Wang et al., 2013).
These studies underline the importance of SOX11 in terminal
differentiation of progenitor cells to neurons and axon extension.
In addition to functioning in neuronal differentiation, SOX11
has a prominent role in the response of neurons to injury. After
peripheral nerve injury, SOX11 is immediately upregulated in
the neuronal cell bodies as the axon is regenerating (Tanabe
et al., 2003; Jankowski et al., 2009). Decreasing levels of SOX11
in the neuronal cell body result in slower axonal regeneration
of peripheral nerves (Jankowski et al., 2009). Similar results
are observed in tissue culture. When Sox11 is knocked down
in cultured peripheral neurons, there is also a reduction in
neurite growth and an increase in apoptosis (Jankowski et al.,
2006). Conversely, overexpressing Sox11 in cultured dorsal root
ganglion cells produces an increase in neurite growth, and in vivo
overexpression of Sox11 accelerates the growth of regenerating
axons (Jing et al., 2012). One intriguing anatomical experimental
model is the dorsal root ganglion, where the central projection
of the dorsal root ganglion enters the spinal cord (CNS) and
the peripheral projection extends out into a peripheral nerve
that is myelinated by Schwann cells. When the central rootlet is
severed, there is a modest (51%) increase in Sox11 expression in
the ganglion even when the central portion will not regenerate
back into the spinal cord. However, when the peripheral root is
damaged, a relatively massive (1004%) increase in Sox11 is seen as
the axons regenerate down the peripheral nerve (Jankowski et al.,
2009).
In the present study, we examine the response of SOX11 in
the retina following injuries to the axons of the optic nerve. We
also explored the potential role of Sox11 in injured RGCs and
regenerated axons. We propose that the upregulation of SOX11
after injury is an attempt of neurons to regenerate, but ultimately
results in abortive regeneration and cell death.
MATERIALS AND METHODS
Mice
All procedures involving animals were approved by the Animal
Care and Use Committee of Emory University and were in
accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research. BXD stains, including their
parental strains, C57BL/6J and DBA/2J, were used for Gene
network database. Sox11f/f mice used for Sox11 downregulation
experiment and the regeneration study were obtained from Dr.
Rafi Ahmed’s labs, which were originally created by Veronique
Lefebvre at Cleveland Clinic (Bhattaram et al., 2010). The mice
were housed in a pathogen-free facility at Emory University,
maintained on a 12 h:12 h light–dark cycle, and provided with
food and water ad libitum.
Optic Nerve Crush
The optic nerve crush (ONC) procedure was performed as
previously described in Templeton and Geisert (Templeton and
Geisert, 2012). Briefly, C57BL/6 or Sox11f/f (four mice per group)
mice were deeply anesthetized with 15 mg/kg xylazine and
100 mg/kg ketamine for the surgery. An incision was made into
the lateral aspect of the conjunctiva, and the eye was rotated
nasally to expose the optic nerve. The optic nerve was then
grasped for 10 s with Dumont cross-clamp #7 forceps (Roboz,
cat. #RS = 5027, Gaithersburg, MD, United States), using only the
spring action of the instrument to crush the nerve. The crush site
is about 1 mm behind the eye to avoid injury to the ophthalmic
artery as mentioned by Wang et al. (2018). The animals were
allowed to recover on a water-circulated heating pad.
In situ Hybridization
In situ hybridization was performed using the 2-plex Quantigene
View RNA ISH Tissue Assay kit (Affymetrix, Inc., Santa
Clara, CA, United States). Assays were performed as per the
manufacturer’s instructions with stock solutions. Eyes were
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isolated from C57BL/6 mice (n = 6), both control and 2 days after
ONC, and drop-fixed in 4% Paraformaldehyde for 24 h. Mid-way
through the 24-h fixation, a 26-gauge needle was used to create
a hole in the cornea, assisting with the fixation. Immediately
after the 24-h period, the eyes were serially dehydrated in
ethanol, cleared with xylenes embedded in paraffin. Blocks
were sectioned on an American Optical series 1000 microtome
(American Optical, Co., Buffalo, NY, United States) to a thickness
of 5 µm and mounted on Surgipath X-tra micro slides (Leica
Biosystems Richmond, Inc., Richmond, IL, United States). Before
beginning the hybridization protocol, the slides were baked
at 60◦C for 30 min to increase tissue adhesion. As per the
manufacturer’s protocol, the paraffin was removed from the
slides with xylene before being boiled in a pretreatment solution
(Affymetrix) for 10 min and incubated with Protein Kinase K
(Affymetrix, Santa Clara, CA, United States) at 40◦C for 10 min.
Custom probes for Sox11 and Chrna6 (Affymetrix, Santa Clara,
CA, United States) were then hybridized to the tissue. Signal
amplification was accomplished by hybridizing Type 1 and Type
2 specific pre-amp oligonucleotides, amp oligonucleotides and
label oligonucleotides sequentially, achieving a 400-fold signal
amplification from each mRNA molecule. Sections were viewed
with an Olympus BX51 microscope (Olympus America, Inc.,
Melville, NY, United States).
Sox11 Partial Knockout
To downregulate Sox11, Sox11f/f mice received intravitreal
injections of AAV2-CMV-GFP-Cre [2 µl of 1012 vg/mL,
expressing Cre recombinase with GFP from a bicistronic vector
(Addgene plasmid #49056), produced by Fred Gage (Kaspar et al.,
2002)]. For the control animals, a vector expressing only GFP
(AAV2-GFP under the CMV promoter) was used. Two weeks
following intravitreal injection, optic nerves were crushed. For
analysis of transduction efficiency, we included four injected
animals (four eyes). Images from five randomly selected fields
of each retina were taken at 20x magnification. The average
transduction efficiency of AAV2 vector was 54%, based on the
number of GFP-positive and RBPMS-positive cells in flat-mount
retinas (Figure 1).
Pten Deletion Induced Regeneration
Model and Quantitation of Axon
Regeneration
We used AAV2-shRNA-Pten-GFP (Pten short hairpin
RNA-GFP packaged into AAV2 backbone constructs,
titer = 1.5 × 1012 vg/ml) for Pten knockdown. The shRNA
target sequence is 5′-AGG TGA AGA TAT ATT CCT CCA A-3′
as described by Zukor et al. (2013). Deletion of Pten is showed to
promote robust axon regeneration after ONC (Park et al., 2008).
Two weeks before ONC, the mice were intravitreally injected
with 2 µl AAV-shRNA-Pten-GFP. Optic crush was performed.
Zymosan (Sigma, St. Louis, MO, United States; Z4250, Lot #
BCBQ8437V) along with cAMP analog CPT-cAMP (Sigma,
C3912, Lot # SLBH5204V) total volume 2 µl were injected into
vitreous immediately following ONC to induce an inflammatory
response and augment regeneration. Twelve days after ONC
FIGURE 1 | Whole mount retinal immunohistochemistry showing AAV
transduction in RGCs. (A) Confocal image of whole mounted retina showing
transduction of AAV2-CMV-GFP. (B) Confocal image of whole mounted retina
showing transduction of AAV2-shRNA- Pten-GFP. (C) Confocal image of flat
mounted retina showing GFP expressing in RGCs. (D) RBPMS label RGCs
specifically as a marker. (E) More than half of RGCs are transduced by AAV
and express GFP; merge image. Scale bar = 100 µm.
(2 days before euthanasia), Alexa Fluor R© 647-conjugated Cholera
Toxin B (CTB; Thermo Fisher, Waltham, MA, United States;
C34778) was injected into the vitreous for anterograde labeling
of the regenerated axons. At 14 days after ONC, the mice were
deeply anesthetized with a mixture of 15 mg/kg of xylazine and
100 mg/kg of ketamine and perfused through the heart with
PBS (Phosphate Buffered Saline, diluted to 1x from 10x stock,
Corning, Manassas, VA, United States, pH 7.3) followed by 4%
paraformaldehyde in phosphate buffer (pH 7.3).
Immunohistochemistry
For the retina whole mount, retina tissues were removed
from the globe after deeply anesthesia and perfusion with 4%
paraformaldehyde, and fixed in 4% paraformaldehyde at room
temperature for 1 h. Following post-fixation, intact retinas were
extracted and washed in PBST (Phosphate Buffered Saline with
Tween 20) with 0.5% Triton X-100. Retinas were blocked in 5%
BSA (Sigma) and 10% donkey serum in PBS for 2 h followed
by incubation with primary antibodies for 24 h at 4◦C. The
following primary antibodies and dilutions were used: anti-
GFP (Novus Biologicals, Littleton, CO, United States; Cat. #
NB100–1770, 1:1000), anti-RBPMS (Millipore, Cat # ABN1376,
Burlington, MA, United States, 1:1000). Then retinas were
washed in PBST three times 10 min each, and incubated in
secondary antibodies in PBST overnight at 4◦C. After another
triplicate wash, retinas were carefully flattened and mounted
on microscopy slides with Fluoromount (Southern Biotech,
Birmingham, AL, United States) and imaged using a Nikon
Eclipse Ti (Nikon, Inc., Melville, NY, United States) confocal
microscope.
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Counting Surviving RGCs and
Regenerating Axons for Statistical
Analysis
Retinal flat-mounts were immunostained with RBPMS antibody
(Millipore, Cat # ABN1376, Burlington, MA, United States) to
label RGCs. For each retina, five fields, whose distance to the optic
nerve were equal, were randomly sampled from middle regions
of each retina under 20x magnification. The density of RGCs per
field was calculated according to the number of RGCs per field.
The GFP and RBPMS double-labeled cells were counted as well,
as the transduced cell results.
Optic nerves along with the optic chiasm were dissected and
post-fixed in 4% paraformaldehyde overnight. The optic nerve
was cleared with FocusClearTM (CelExplorer, Hsinchu, Taiwan)
until totally transparent. FocusClear allows us to scan the whole
thickness of the optic nerve for better understanding of the status
of axon regeneration and provide clear imaging of regenerated
axons from the optical slices scanned by confocal microscope for
counting. The quantitation of axon regeneration was determined
by counting the longest five axons or the longest single axon
along the whole nerve. Both the distance the axons traveled and
the number of axons at 0.5 and 1 mm behind the crush site
were measured as described in Wang et al. (2018). Pseudocolor
of green was used to show the CTB-labeled axons in all the
optic nerve images of this study for clear visual observation.
Data are presented as mean ± standard error of the mean
(SEM). Differences in axon counts, regeneration distance, and
transduction efficiency were analyzed with the Mann–Whitney
U-test using SPSS Statistics package 24.0 (SPSS, IBM, Chicago,
IL, United States). A p-value of less than 0.05 was considered
statistically significant.
All the experiments were done following standard biosecurity
and institutional safety procedures.
RESULTS
The Distinct Expression Changes of
Sox11 Following Injuries to the Axons of
the Optic Nerve
To define the changes in Sox11 that occur following injury to the
optic nerve, we compared Sox11 mRNA levels in normal mice
to Sox11 levels following ONC using the bioinformatic tools on
GeneNetwork1. The levels of Sox11 mRNA were examined using
the Normal HEI Retina (April, 2010) Database and comparing
it to the ONC HEI Retina (April, 2012) Database (Freeman
et al., 2011; Templeton et al., 2013). Sox11 was one of the genes
with the largest change in expression 2 days after ONC. In the
normal retinal dataset, the mean expression for Sox11 (detected
by Illumina probe ILMN_1235647) across the BXD RI strains was
8.4 on a log2 Z-scale (The mRNA expression levels are expressed
on a custom z-scale according to the formula 2Z + 8 so that the
mean expression of all mRNAs on the array equals 8) (Parker
et al., 2017). In the C57BL/6 parental strain, the expression level
1http://genenetwork.org
in the normal retina was 8.59 and for the DBA/2J strain the
mean expression level was 8.54. Two days after ONC, there was a
dramatic increase in the level of Sox11 expression (Figure 2), with
the mean expression across the BXD strains being 11.03, which
corresponded to an approximately eightfold increase. The same
increase was observed in individual strains. The C57BL/6 strain
had an expression level of 11.33 after ONC and the expression
in the DBA/2J strain increased to 11.44. These data indicate that
Sox11 is dramatically upregulated after a specific injury to the
ganglion cell axons within the optic nerve.
Expression Pattern of Sox11 in Naïve
Adult Retina and Injured Adult Retina
In situ hybridization was used to identify the cells expressing
Sox11 after injury to the retina. For the in situ hybridization, we
examined retinas 2 days after ONC (Figure 3B) and compared
it to uninjured control retinas (Figure 3A). Using the Affymetrix
2-plex Quantigene View RNA ISH Tissue Assay kit, we labeled
cells expressing the RGC marker Chrna6 blue and Sox11 red
(Figure 3) (Munguba et al., 2013). In the control retina, many
of the cells in the ganglion cell layer were heavily labeled for
Chrna6, and a few of the cells expressed marginal levels of
Sox11. Two days after ONC there was a dramatic decrease in
the labeling for Chrna6 and a substantial increase in the amount
of labeling for Sox11. This change was similar trend to the
changes in message levels observed in our microarray databases
on GeneNetwork.org. In the normal retina database, Chrna6
(probe ILMN_2732438) was expressed at relatively high levels
(mean value of 11.04) and 2 days following ONC, the expression
decreased twofold (mean value of 9.96). These data from the
in situ hybridization mirror our microarray expression analysis
results.
Downregulation of Sox11 Facilitates RGC
Survival Following Optic Nerve Crush
To define the role of Sox11 in the response of RGC to Injury,
an AAV2 vector expressing Cre and GFP was used for Sox11
partial knockout in RGCs of the Sox11f/f mice (Figure 4). The
retinas containing Sox11 partial knockout cells were compared
to retinas treated in a similar manner using AAV2-GFP vectors.
Two weeks after the intravitreal injection of the AAV2-Cre-GFP
or AAV2-GFP vectors, the optic nerve was crushed. Following
a 26-day survival, the eyes were injected with fluorescence-
labeled CTB and the animals were sacrificed 2 days later. These
data were compared to control retinas injected with AAV2-GFP
vector that did not receive a nerve crush (Figure 4B). The flat
mounted retinas were immunostained for RBPMS to label RGCs.
When examining the retinas, we found an increased number
of GFP-labeled RGCs in the Sox11 partial knockout animals
relative to the GFP control animals (Figures 4B,C). It is also the
case for all of the RBPMS labeled RGCs (Figures 4B,D). There
were fewer RGCs left in the GFP control retinas relative to the
retinas where Sox11 was partially knocked out. These results were
quantified, counting the number of GFP-labeled RGCs (double
labeled by GFP and RBPMS, Figure 4C) and total RGCs (labeled
by RBPMS, Figure 4D) to define the effects of partially knocking
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FIGURE 2 | Sox11 expression in the normal retina and after optic nerve crush (ONC). (A) The ordinate represents mRNA levels from microarrays, expressed in a log2
scale with the mean set to 8. The mice used to generate these data were C57BL/6, DBA/2J, their respective F1 crosses, BALB/cByJ, and members of the BXD
recombinant inbred strain line. The top graph denotes the expression levels of Sox11 under normal conditions, while the bottom graph denotes the expression of
Sox11 2 days after the ONC. (B) Note the dramatic increase in expression following injury, from a normal mean expression value of 8.4 to a mean expression value of
11.0 after nerve crush, which corresponded to an approximately eightfold increase.
out Sox11. The normal retinas (without ONC) had 1782 GFP-
labeled RGCs/mm2 (SE 130 Cells/mm2, n = 4). In the crushed
retinas that received AAV2-GFP, the average number of GFP-
labeled RGCs was 158/mm2 (SE 15.7 Cells/mm2, n = 4); while,
in the retinas receiving AAV2-Cre-GFP, the average number of
GFP-labeled RGCs 357 RGCs/mm2 (SE 7.1 Cells/mm2, n = 4).
This 125.9% increase in RGC survival between AAV2-GFP group
and AAV2-Cre-GFP group is statistically significant (p = 0.029,
Mann–Whitney U-test, n = 4, Figure 4C). Interestingly, if we
examine the number of RBPMS-labeled RGCs in the same retinas
(Figure 4D), with a dramatic decrease caused by the ONC, a
similar protective effect observed in the retinas in which Sox11
was knocked down using AAV2-Cre-GFP (Figure 4D). Without
ONC, the retinas had 3389 RBPMS-labeled RGCs/mm2 (SE 92.1
Cells/mm2, n = 4). In the crushed retinas that received AAV2-
GFP, the average number of total RGCs was 828/mm2 (SE 22.9
Cells/mm2, n = 4); while, in the retinas receiving AAV2-Cre-
GFP, the average number of total RGCs 1398 RGCs/mm2 (SE
62.9 Cells/mm2, n = 4). Partial knockout Sox11 had a significantly
positive effect on the survival of the RGC cell body 14 days after
ONC (p = 0.028, Mann–Whitney U-test, n = 4). Thus, a partial
knockout of Sox11 not only rescued the transduced cells missing
Sox11 but there was also a significant increase in survival of
non-transduced RGCs in retinas.
Sox11 Partial Knockout Does Not
Facilitate Axon Regeneration
When we examined the optic nerve in the same set of mice, we
did not observe any significant increase in axonal regeneration
FIGURE 3 | In situ hybridization for Sox11 and Chrna6. The distribution of
Sox11 and Chrna6 mRNA was defined using two-color in situ hybridization for
a section of control retina (A) and a section of a retina 2 days after ONC (B).
The probe for Chrna6 is shown in blue and that for Sox11 in red. Note the
extensive staining for Chrna6 within the ganglion cell layer in the control
section (Arrows in A). Two days after ONC there is already a substantial
decrease in Chrna6 expression. Very low levels of Sox11 are seen in the
control retina. There is a dramatic increase in Sox11 staining after nerve crush
within the retinal ganglion cells (RGCs) (Arrows in B). (A,B) Are taken at the
same magnification and the scale bar in (B) = 25 µm.
that was due selectively to the partial knockout Sox11. We
examined axon regeneration following ONC in four groups of
mice: C57BL/6J controls; Sox11f/f controls; Sox11f/f that received
an intravitreal injection of AAV2-GFP; and, Sox11f/f that received
an intravitreal injection of AAV2-Cre-GFP. The number of
regenerating axons in the damaged optic nerve and the distance
the axons traveled along the nerve was measured. There was
very little axonal regeneration in the control groups and no
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FIGURE 4 | Downregulation of Sox11 facilitates RGC survival following ONC. (A) Sox11 is partially knocked out by intravitreal injection of AAV2-CMV-Cre-GFP in 4
to 6-week-old Sox11f/f mice. The control group receives AAV2-CMV-GFP. Optic nerve crush is performed 2 weeks after viral vector injection. Twelve days after ONC,
Alexa Fluor 647-conjugated cholera toxin B (CTB) is used to label regenerating axons. Two days later mice are sacrificed. (B) For the retinal whole mounts, RGCs are
labeled with the pan-RGC marker RBPMS. The number of AAV2-GFP vector transduced RGCs without crush injury is 1782 ± 117.5/mm2. (C) Downregulation of
Sox11 in RGCs greatly increases the survival of AAV2 vector transduced RGCs (double labeled by GFP and RBPMS) after ONC as compared to AAV2-CMV-GFP
injection with ONC group (357 ± 7.1/mm2 vs. 158 ± 15.7/mm2, n = 4, p = 0.029, Mann–Whitney U-test). (D) The number of total RGCs labeled by RBPMS without
crush injury is 3389 ± 92.1/mm2. When comparing the total RGCs labeled by RBPMS, it shows that Sox11 partial knockout in the Sox11f/f mice significantly
increases RPBMS-positive RGC survival after ONC as compared to AAV2-CMV-GFP ONC group (1398 ± 63/mm2 vs. 828 ± 23/mm2, n = 4, p = 0.028,
Mann–Whitney U-test). Scale bar = 100 µm.
statistical difference between the C57BL/6J controls and the
Sox11f/f controls. There was a significant difference (p < 0.05,
Mann–Whitney U-test, n = 4) between these two control groups
and the Sox11f/f mice that received intravitreal injections of either
AAV2-GFP or AAV2-Cre-GFP. However, there was no difference
in the partial knockout of Sox11 compared to the GFP control
groups (Figure 5). These data suggest that a partial knockout of
Sox11 does not facilitate axon regeneration in the injured optic
nerve. Furthermore, the AAV treatment alone (either AAV2-GFP
treated Sox11f/f mice or AAV2-Cre-GFP Sox11f/f mice) produces
a significant increase in regeneration compared to ONC only
mice (non-treated C57BL/6J mice or non-treated Sox11f/f mice).
We do not fully understand this effect of AAV in the Sox11f/f
mice; however, it is a consistent result. We assume that there is
some interaction between the AAV vector and the genome of the
Sox11f/f mice, facilitating axon regeneration.
Downregulation of Sox11 Suppresses
Induced Axon Regeneration
To examine the potential contribution of Sox11 to optic nerve
axonal regeneration, a combined partial knockout of both Sox11
and Pten was examined. Knocking down Pten with the AAV2-
shRNAPten vector resulted in a significant amount of axonal
regeneration 2 weeks after ONC. The eyes that received AAV2-
GFP and AAV2-shRNAPten had a significant increase in the
number of axons regenerating 0.5 mm from the crush site and an
increase in the distance that longest axon traveled (Figure 6A). In
the GFP control optic nerve the number of axons at 0.5 mm from
the crush site was 261 ± 19 (n = 4) and the longest regenerating
axon found in the optic nerve was on average 0.92 mm (Figure 6A).
Following AAV2-shRNAPten, the number of axons at 0.5 mm
increased to 908± 24 (n = 4) and the longest axon was on average
2.18 mm from the crush site. When Sox11 was partially knocked
out in mice that also received the AAV2-shRNAPten treatment,
there was a surprising decrease in the regenerative response in
the optic nerve (Figure 6A). In the Sox11 partial knockout optic
nerve the number of axons at 0.5 mm from the crush site was
384 ± 47 (n = 4) and the longest regenerating axon found in
the optic nerve was on average 1.09 mm (Figures 6B–E). This
represents a significant decrease in the number of regenerating
axons (p = 0.02, Mann–Whitney U-test, n = 4) and the distance
traveled (p = 0.021, Mann–Whitney U-test, n = 4).
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FIGURE 5 | Representative images of optic nerves showing regenerating axons from different groups at 2 weeks after injury. (A) Pseudocolor green was used for the
CTB-labeled axons in all the optic nerve images of this study for clear visual observation (red asterisks represent the crush site). Quantification axon number at
0.5 mm (B) and 1 mm (C) from crush site reveals that there is a statistically significant increase in the number of axons following an injection of either AAV2-GFP or
AAV2-Cre-GFP in the Sox11f/f mice relative to ether the C57BL/6J control of the Sox11f/f control. This indicates that the increased axon regeneration is due to the
use of AAV2-gene delivery systems in the retina and not the partial knockout of Sox11. A similar result was observed for the distance of longest five regenerating
axons traveled (D) and the distance of longest single regenerating axons (E). Again, the most regeneration was observed in the animals that received gene delivery in
the retina by AAV2 vectors. There was a significant difference (p < 0.05, n = 4, Mann–Whitney U-test) between the ONC only mice and the Sox11f/f mice that
received intravitreal injections of either AAV2-GFP or AAV2-Cre-GFP. No statistic difference was found between the two ONC only groups. No statistic difference was
found between the Sox11 pKO and the GFP control groups. N = 4 per group. Scale bar = 200 µm.
The decrease in axonal regeneration observed in the
Pten/Sox11 double knockdown group was not due to a decrease
in the number of surviving RGCs at 2 weeks following crush
(Figure 7). In the animals that received AAV2-shRNAPten only,
the average number of surviving RGCs was 722 ± 77/mm2.
Partial knockout of Sox11 in addition to Pten knockdown
resulted in an increase in RGC survival with an average of
1393 ± 94/mm2 RGCs. This increased survival was statistically
significant (p = 0.034, Mann–Whitney U-test, n = 4) (Figure 7C).
The data of RGCs number in all experimental groups were
summarized in Figure 8.
DISCUSSION
Sox family members are key regulators of neuron differentiation
during development and axon regeneration after injury
(Jankowski et al., 2006; Moore and Goldberg, 2011; Mu et al.,
2012; Kuwajima et al., 2017; Wang et al., 2018). They are
intimately involved in RGC differentiation and in the formation
of the optic nerve (Chang et al., 2017). In the present study, we
demonstrate that Sox11 is upregulated following retinal injury.
For RGCs, there are many known markers, such as: Chrna6,
Pou4f1, Tubb3, Thy1, or Sncg (Barnstable and Drager, 1984;
Gan et al., 1996; Mu et al., 2004; Surgucheva et al., 2008; Prasov
and Glaser, 2012; Jiang et al., 2013; Munguba et al., 2013).
Using these marker genes, we performed a meta-analysis of
their expression in injured and uninjured retinas. Our injury
paradigms included controlled ONC procedures that are known
to induce RGC apoptosis (Hines-Beard et al., 2012; Templeton
and Geisert, 2012). As expected, the expression of these RGC
markers decreases as the ganglion cells die. Our data indicate
an overall reduction in expression of these markers, both 2 and
5 days after retinal insult (Geisert et al., 2009). Specifically, a
threefold reduction in Sncg expression is observed, Chrna6 and
Pou4f1 are downregulated twofold, and, while not as robust,
Thy1 and Tubb3 also show a decrease in expression. Collectively,
these data demonstrate that known RGC markers decrease as the
optic nerve degenerates.
Unlike these RGC markers, Sox11 levels increase substantially
following the initial injury to the retina or optic nerve. Two
days after ONC, there was an almost eightfold upregulation of
Sox11. We wondered if this increase in expression was specific
to the severity of retinal injury, and queried a publicly available
microarray dataset of glaucomatous mice presented by Howell
and colleagues as an independent test on the role of Sox11 in
the response of the retina to injury (Howell et al., 2011). In
this DBA/2J mouse model of pigment dispersion glaucoma, there
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FIGURE 6 | Representative images of optic nerves showing regenerating axons from different groups at 2 weeks after injury. (A) Pseudocolor green was used for
the CTB-labeled axons in all the optic nerve images of this study for clear visual observation (red asterisks represent the crush site). Quantitative analysis of axon
regeneration revealed that downregulation of Sox11 suppresses the RGC axon regeneration following silencing of Pten. (B) The results were quantified and are
displayed in a series of bar graphs showing mean and standard error of the mean in the number of regenerating axons at 0.5 mm from crush site (n = 4, ∗p < 0.05,
Mann–Whitney U-test), (C) the number of regenerating axons at 1 mm from crush site (n = 4, ∗p < 0.05, Mann–Whitney U-test), (D) the longest five regenerating
axons (n = 4, ∗p < 0.05, Mann–Whitney U-test), and (E) the longest single regenerating axon (n = 4, ∗p < 0.05, Mann–Whitney U-test). Scale bar = 200 µm.
were relatively low levels of Sox11 in the control mice and in mice
that did not have detectable levels of ganglion cell loss (Figure 9).
However, in mice with moderate ganglion cell loss, levels of Sox11
were approximately fourfold higher than in control animals. In
animals with severe glaucoma, the level of Sox11 decreased to
near control levels. These data suggest that the levels of Sox11
decrease as the ganglion cells die. This transient upregulation
of Sox11 in moderate cases demonstrates the exquisite ability
of Sox11 to mark injured, potentially dying neurons. A similar
pattern was observed following ONC in C57BL/6 and DBA/2J
where Sox11 is upregulated over twofold 2 days after nerve
crush and over threefold 5 days after nerve crush (Templeton
et al., 2013). Previous studies have implicated artificially high
levels of Sox11 to promote regeneration in PNS (Jankowski et al.,
2009; Jing et al., 2012; Chandran et al., 2016) and corticospinal
axons (Wang et al., 2015). Gene profiling showed that Sox11
overexpression activated a set of developmental genes which are
possibly related to axon growth and that it downregulated genes
involved in synaptic transmission. This was consistent with the
notion of a developmental process switch from axon growth
mode of immature neurons to dendrite or synapse growth mode
in mature neurons. Thus, Sox11 may be regarded as a master
reprogramming regulator in the nervous system. Therefore, these
data confirm our hypothesis that upregulation of Sox11 after
injury is an attempt by neurons to regenerate.
What is the potential role of SOX11 following injury to
the RGCs and the axons? Due to our result that injury
caused upregulation of Sox11 in different injury models, we
downregulated Sox11 2 weeks before ONC injury by Cre/LoxP
system in vivo in order to validate our finding. After injury,
the downregulation of Sox11 resulted in a higher survival rate
of RGCs; however, no effect was seen on axon regeneration.
Interestingly, we found that partially knocking out Sox11 not
only increased the survival of transduced cells but also had
increased the survival rate of cells not transduced by the AAV2-
Cre-GFP. External signals from microenvironment together with
intrinsic signaling pathways determine whether a particular
neuron will die (Pfisterer and Khodosevich, 2017). This is a
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FIGURE 7 | Downregulation of Sox11 facilitates RGC survival following optic nerve crush and regeneration experiment. (A) Sox11 and Pten are knocked down by
intravitreal injection of AAV2-CMV-Cre-GFP or AAV2-shRNA-Pten-GFP in 4 to 6 week-old Sox11f/f mice. The control group receives AAV2-CMV-GFP. Optic nerve
crush is performed 2 weeks after viral vector injection. Twelve days after ONC, Alexa Fluor R© 647-conjugated CTB is used to label regenerating axons. Two days after
the CTB injections the animals are sacrificed, the retinas and full-length optic nerves are removed. (B) RGCs are labeled with pan-RGC marker RBPMS in retinal
whole mounts. (C) Downregulation of both Sox11 and Pten resulted in a significant increase in RGC survival as compared to Pten knockdown only (1393 ± 94/mm2
vs. 722 ± 77/mm2, n = 4, ∗p < 0.05, Mann–Whitney U-test). Scale bar = 100 µm.
clear indication that there is a cell intrinsic effect of partially
knocking out Sox11, as can be seen in the increased survival of
cells in which Sox11 is knocked out. There is also a clear cell
extrinsic effect with an increased survival of the non-transduced
RGCs following the partial knockout of Sox11. These effects
may be due to altered expression of Sox11 downstream targets.
Several studies have identified downstream targets of Sox11 using
ChIP-seq technologies (Bergsland et al., 2011; Kuo et al., 2015),
including FGF2 and NGF, members of the WNT singling pathway
(Ohlmann and Tamm, 2012) and TGF pathway (Garcia et al.,
2017). Sox11 is also reported to regulate the expression of BDNF
(Salerno et al., 2012; Struebing et al., 2017) and GNDF (Jankowski
et al., 2018), neurotropic factors known to regulate neuronal
survival (Pfisterer and Khodosevich, 2017). It would not be
surprising if some of these downstream targets of Sox11 were
responsible for the cell extrinsic effects associated with the partial
knockout of Sox11 in the retina.
We also observed that RGCs transduced with AAV vectors
were more susceptible to ONC injury than non-transduced RGCs
in the same retina. At the present time we have no direct evidence
to explain this apparent difference in survival; however, it is clear
that there is a decrease in the survival rate of AAV transduced
RGCs. There are two potential explanations for this AAV induced
susceptibility. The first is that AAV2 specifically transduces RGCs
that are more susceptible to injury. Although, we do not have
any direct evidence to prove this hypothesis, we do know that
there is cell type selectivity in AAV transduction (Dinculescu
et al., 2005; Belur et al., 2008; Watakabe et al., 2015; Smith and
Chauhan, 2018). A second possibility is that the transduction by
AAV-GFP itself could make RGCs be more sensitive to damage,
for example, caused by some toxic effect of AAV- GFP vector
(Khabou et al., 2018). It is also possible that the expression of
GFP itself may result in increased susceptibility to injury (Ganini
et al., 2017). Independent of the mechanism, our data reveals
that the transduced cells are more susceptible to death following
ONC.
In the PNS, similar response of dorsal root ganglion neurons
to peripheral nerve injury was found. Sox11 is dramatically
upregulated in the dorsal root ganglion following injury to the
peripheral nerve and plays a pivotal role in axonal regeneration
(Jankowski et al., 2009). Three days after the transection of the
sciatic nerve in the rat, there is a 1004% increase in Sox11 in
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FIGURE 8 | Comparison of RGCs survival following different conditions in Sox11f/f mice. Total RGCs numbers labeled by RBPMS from six different conditions are
shown as: naïve retina, crushed only retina, GFP control vector injected retina, Sox11 partial knockout, Pten knockdown retina, Pten/Sox11 double knockdown
retina. Sox11 deletion aids more RGCs survive after injury. Sox11 deletion aids more RGCs survive after ONC 2 weeks.
FIGURE 9 | Sox11 mRNA Levels in Pigmentary Glaucoma. Sox11 levels in a meta-analysis of a DBA/2J mouse pigmentary glaucoma dataset from Howell et al.
(2011). The ordinate represents the Sox11 mRNA level from microarrays, expressed in log2, scaled with the mean set to 8. The mice were classified as wild type
Gpnmb+/+ controls (Gpnmb+ Controls), no detectable glaucoma 1 (NOE 1), no detectable glaucoma 2 (NOE2), moderate glaucoma (Moderate), and severe
glaucoma (Severe). Other than the wild type group, all the groups were Gpnmb−/−. Notice that there is a dramatic increase in Sox11 expression during early phases
of glaucoma in this mouse model. As the ganglion cells die in severe glaucoma, the expression levels of Sox11 decrease. These data suggest that Sox11 is an early
marker for retinal injury. This general expression pattern was observed for the following 5 of the 6 Affymetrix probe sets targeting Sox11: 1429051_s_at (illustrated
above), 1453002_at, 1429372_at, 1453125_at, and 1431225_at.
the dorsal root ganglion and these levels remain elevated for at
least the next 4 days (Jankowski et al., 2009). By 4 weeks after
transection, Sox11 levels returned to baseline. This upregulation
and sustained expression of Sox11 is critical to the survival of the
dorsal root ganglion neurons and the regeneration of peripheral
axons along the injured nerve. When the levels of Sox11 were
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FIGURE 10 | A schematic illustration depicting the role of Sox11 regulation in RGCs survival and axon regeneration. The differential response is observed in both
overexpressing Sox11 or knocking-down Sox11. Upregulation of Sox11 promotes robust axon regeneration of some RGCs types but kills α-RGCs (Norsworthy
et al., 2017). Downregulation of Sox11 aids RGCs survival (Welsbie et al., 2017) but negates the axon regeneration facilitated by Pten deletion.
knocked down by delivery of siRNA in an in vitro study, there
was an increase in neural apoptosis as well as a decrease in neurite
outgrowth (Jankowski et al., 2006). It showed that apoptosis-
related genes that are regulated by Sox11, like Tank, Bnip3, Blk
and Bcl10, may therefore contribute to the increased number of
apoptotic cells in the Sox11-deficient cells. It seems likely that this
result is not completely consistent with ours. Potential reasons
include different experimental conditions (in vivo or in vitro),
or different cultured cells. Jankowski showed that In vivo, Sox11
knockdown reduced the elevation of ATF3 following PNS injury,
whereas in vitro, this knockdown led to a decrease in ATF3
expression (Jankowski et al., 2009).
Recently, Welsbie et al. (2017) identified Sox11, as a major
downstream mediator of RGC death through DLK/LZK signal
activation. Their data with human stem cell-derived RGCs
showed that after injury, primary RGCs increased Sox11
mRNA expression. Moreover, Sox11 knockdown had a survival-
promoting effect on injured RGCs, which is consistent with our
findings in vivo. Norsworthy et al. (2017), who were also using an
in vivo approach, found that SOX11 is preferentially involved in
the death of alpha RGCs. In addition, their data also implicated
Sox11 in axon regeneration following ONC. In our study, we
further verified that downregulation of Sox11 counters axon
regeneration facilitated by Pten knockdown. A similar decrease
in axonal regeneration occurred in vivo after Sox11 knockdown
in the dorsal root ganglion (Jankowski et al., 2009). Thus, the
upregulation of Sox11 is believed to be necessary for the normal
regeneration of axons in the peripheral nerve. Jankowski et al.
(2006) pointed out that one possible transcriptional target of
SOX11, ARPC3, a protein that is thought to contribute to actin
filament nucleation, may be involved in neurite extension and
branching (Jankowski et al., 2006). Although further validation
is required in the future, this finding still provides new insight
underlying axon growth, and how the injury signal is relayed
to the cell body, resulting in either cell death or regenerative
response. Interestingly, Sox11 was also upregulated when the
central projection of the dorsal root was severed; however, the
degree of upregulation was lower, only 51% (Jankowski et al.,
2006, 2009). The most parsimonious explanation is that these
neurons are attempting to survive using the same program that
is successful in peripheral nerve injury; however, other influences
derail the regenerative program, causing the cell to abort the
regenerative process and, in many cases, cause subsequent
neuronal death (Geisert et al., 1996; Schwab and Bartholdi, 1996;
Silver and Miller, 2004; Harel and Strittmatter, 2006). Recent
evidence indicates that these inhibitory influences can at least
be partially averted by stimulating the ganglion cells to regrow
their axons (Leibinger et al., 2009; Muller et al., 2009; Park et al.,
2009, 2010; Smith et al., 2009; de Lima et al., 2012; Pernet et al.,
2013).
SOX11 plays a critical role in regulating neuronal
development, and has a potential promotion effect on axon
regeneration. The effect of SOX11 appears to be dependent on
the surrounding environment: it can either be reprogramming,
or dedifferentiating (Aubert et al., 1995). Given that upregulation
of Sox11 is among the initial responses of the neuron to injury
and that this response is intact in RGCs, it may be possible
to identify where the transcriptional cascade leading to axon
regeneration and cell survival in the CNS differs from that in
peripheral nerve injury. Taken together, we found different
neuron components (cell body and axons) may respond uniquely
to genetic modulation. This differential response is observed
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in both overexpressing Sox11 or knocking-down Sox11. We
found that a partial knockout of Sox11 resulted in an increase
in RGC survival and a decrease in axonal regeneration; while,
Norsworthy et al. (2017) found that over expressing Sox11 had
the opposite effect with a selective loss of specific RGC cell types
and a facilitation of axonal regeneration (Figure 10). Therefore,
in the future treatment of neural repair and axon regeneration,
gene therapy is recommended to be designed specifically for
multiple therapeutic targets to achieve optimal outcomes for
neural recovery.
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